ArticleScientific reports2023

Empagliflozin reduces arrhythmogenic effects in rat neonatal and human iPSC-derived cardiomyocytes and improves cytosolic calcium handling at least partially independent of NHE1.

Danúbia Silva Dos Santos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.